Immunostimulating IL-2 analogs
US12415842B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2023 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | Nov 5, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modifications to interleukin-2 alpha receptors are disclosed. Interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.